Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Berrocal

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Rheumatology|November 17, 2018
Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease - Scleroderma Clinical Trials ConsortiumZsuzsanna H McMahan, Tracy Frech, Veronica Berrocal, et al.
International Journal of Environmental Research and Public Health|March 4, 2016
Evaluating the Appropriateness of Downscaled Climate Information for Projecting Risks of SalmonellaGalina S Guentchev, Richard B Rood, Caspar M Ammann, et al.
Arthritis Research & Therapy|January 7, 2021
Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosisDavid A Fox, Steven K Lundy, Michael L Whitfield, et al.
Arthritis Research & Therapy|March 5, 2021
Correction to: Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosisDavid A Fox, Steven K Lundy, Michael L Whitfield, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2019
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialDinesh Khanna, Cathie Spino, Sindhu Johnson, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Rheumatology|November 17, 2018
Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease - Scleroderma Clinical Trials ConsortiumZsuzsanna H McMahan, Tracy Frech, Veronica Berrocal, et al.
International Journal of Environmental Research and Public Health|March 4, 2016
Evaluating the Appropriateness of Downscaled Climate Information for Projecting Risks of SalmonellaGalina S Guentchev, Richard B Rood, Caspar M Ammann, et al.
Arthritis Research & Therapy|January 7, 2021
Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosisDavid A Fox, Steven K Lundy, Michael L Whitfield, et al.
Arthritis Research & Therapy|March 5, 2021
Correction to: Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosisDavid A Fox, Steven K Lundy, Michael L Whitfield, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2019
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialDinesh Khanna, Cathie Spino, Sindhu Johnson, et al.
Pageof 2